{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:40:23Z","timestamp":1792010423767,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the National Key Research and Development Program of China","award":["2018YFC2000500"],"award-info":[{"award-number":["2018YFC2000500"]}]},{"name":"the National Key Research and Development Program of China","award":["2022YFC2303100"],"award-info":[{"award-number":["2022YFC2303100"]}]},{"name":"Henan Province Medical Science and Technology Program Provincial and Ministerial Joint Projects","award":["SBGJ202003024"],"award-info":[{"award-number":["SBGJ202003024"]}]},{"name":"Research Project of Jinan Microecological Biomedicine Shandong Laboratory","award":["JNL-2022001A"],"award-info":[{"award-number":["JNL-2022001A"]}]},{"name":"Research Project of Jinan Microecological Biomedicine Shandong Laboratory","award":["JNL-2022015B"],"award-info":[{"award-number":["JNL-2022015B"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Alterations in oral microbiota in patients with systemic lupus erythematosus (SLE) is less evaluated. The aim of this study was to compare the characteristics of the oral microbiome in SLE patients and healthy controls, and construct an SLE classifier based on the oral microbiota.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We sequenced tongue-coating samples of individuals in treatment-na\u00efve SLE (n\u2009=\u2009182) and matched healthy controls (n\u2009=\u2009280). We characterized the oral microbiome and constructed a microbial classifier in the derivation cohort and validated the results in the validation cohorts. Furthermore, the oral microbiome of posttreatment SLE (n\u2009=\u200973) was characterized.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The oral microbial diversity of SLE was increased, and the microbial community was different between SLE and healthy controls. The genera Prevotella and Veillonella were enriched, while Streptococcus and Porphyromonas were reduced in SLE. In addition, an increase was noted in 27 predicted microbial functions, while a decrease was noted in 34 other functions. Thirty-nine operational taxonomy units (OTUs) were identified to be related with seven clinical indicators. Two OTUs were identified to construct a classifier, which yielded area under the curve values of 0.9166 (95% CI 0.8848\u20130.9483, p\u2009&lt;\u20090.0001), 0.8422 (95% CI 0.7687\u20130.9157, p\u2009&lt;\u20090.0001), and 0.8406 (95% CI 0.7677\u20130.9135, p\u2009&lt;\u20090.0001) in the derivation, validation, and cross-regional validation groups, respectively. Moreover, as disease activity increased, Abiotrophia and Lactobacillales increased, while Phyllobacterium and unclassified Micrococcusaceae decreased. Finally, nine OTUs were selected to construct a classifier distinguishing posttreatment SLE patients from healthy controls, which achieved a diagnostic efficacy of 0.9942 (95% CI 0.9884\u20131, p\u2009&lt;\u20090.0001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study comprehensively characterizes the oral microbiome of SLE and shows the potential of the oral microbiota as a non-invasive diagnostic biomarker in SLE.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-023-03892-3","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T06:04:36Z","timestamp":1675836276000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Alterations in the human oral microbiota in systemic lupus erythematosus"],"prefix":"10.1186","volume":"21","author":[{"given":"Jinyan","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangying","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanmin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suying","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zujiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0798-3444","authenticated-orcid":false,"given":"Zhigang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,8]]},"reference":[{"key":"3892_CR1","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"365","author":"GC Tsokos","year":"2011","unstructured":"Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365:2110\u201321.","journal-title":"N Engl J Med"},{"key":"3892_CR2","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1093\/rheumatology\/kex260","volume":"56","author":"F Rees","year":"2017","unstructured":"Rees F, Doherty M, Grainge MJ, Lanyon P, Zhang W. The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology. 2017;56:1945\u201361.","journal-title":"Rheumatology"},{"key":"3892_CR3","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0140-6736(13)61499-3","volume":"382","author":"F Goldblatt","year":"2013","unstructured":"Goldblatt F, O\u2019Neill SG. Clinical aspects of autoimmune rheumatic diseases. Lancet. 2013;382:797\u2013808.","journal-title":"Lancet"},{"key":"3892_CR4","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/ni.2604","volume":"14","author":"Y Belkaid","year":"2013","unstructured":"Belkaid Y, Naik S. Compartmentalized and systemic control of tissue immunity by commensals. Nat Immunol. 2013;14:646\u201353.","journal-title":"Nat Immunol"},{"key":"3892_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature11234","volume":"486","author":"Human Microbiome Project Consortium","year":"2012","unstructured":"Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207\u201314.","journal-title":"Nature"},{"key":"3892_CR6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature05698","volume":"446","author":"A Nenci","year":"2007","unstructured":"Nenci A, Becker C, Wullaert A, Gareus R, van Loo G, Danese S, Huth M, Nikolaev A, Neufert C, Madison B, et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature. 2007;446:557\u201361.","journal-title":"Nature"},{"key":"3892_CR7","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.cell.2006.02.017","volume":"124","author":"RE Ley","year":"2006","unstructured":"Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell. 2006;124:837\u201348.","journal-title":"Cell"},{"key":"3892_CR8","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.berh.2017.09.005","volume":"31","author":"CG Parks","year":"2017","unstructured":"Parks CG, de Santos ASE, Barbhaiya M, Costenbader KH. Understanding the role of environmental factors in the development of systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2017;31:306\u201320.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"3892_CR9","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1080\/19490976.2020.1768644","volume":"11","author":"M Guo","year":"2020","unstructured":"Guo M, Wang H, Xu S, Zhuang Y, An J, Su C, Xia Y, Chen J, Xu ZZ, Liu Q, et al. Alteration in gut microbiota is associated with dysregulation of cytokines and glucocorticoid therapy in systemic lupus erythematosus. Gut Microbes. 2020;11:1758\u201373.","journal-title":"Gut Microbes"},{"key":"3892_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jaut.2016.07.004","volume":"75","author":"C Lippens","year":"2016","unstructured":"Lippens C, Duraes FV, Dubrot J, Brighouse D, Lacroix M, Irla M, Aubry-Lachainaye JP, Reith W, Mandl JN, Hugues S. IDO-orchestrated crosstalk between pDCs and Tregs inhibits autoimmunity. J Autoimmun. 2016;75:39\u201349.","journal-title":"J Autoimmun"},{"key":"3892_CR11","doi-asserted-by":"publisher","first-page":"24072","DOI":"10.1038\/srep24072","volume":"6","author":"P L\u00f3pez","year":"2016","unstructured":"L\u00f3pez P, de Paz B, Rodr\u00edguez-Carrio J, Hevia A, S\u00e1nchez B, Margolles A, Su\u00e1rez A. Th17 responses and natural IgM antibodies are related to gut microbiota composition in systemic lupus erythematosus patients. Sci Rep. 2016;6:24072.","journal-title":"Sci Rep"},{"key":"3892_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11926-021-00986-z","volume":"23","author":"R Li","year":"2021","unstructured":"Li R, Meng X, Chen B, Zhao L, Zhang X. Gut microbiota in lupus: a butterfly effect? Curr Rheumatol Rep. 2021;23:27.","journal-title":"Curr Rheumatol Rep"},{"key":"3892_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fimmu.2017.00023","volume":"8","author":"J Rodr\u00edguez-Carrio","year":"2017","unstructured":"Rodr\u00edguez-Carrio J, L\u00f3pez P, S\u00e1nchez B, Gonz\u00e1lez S, Gueimonde M, Margolles A, de Los Reyes-Gavil\u00e1n CG, Su\u00e1rez A. Intestinal dysbiosis is associated with altered short-chain fatty acids and serum-free fatty acids in systemic lupus erythematosus. Front Immunol. 2017;8:23.","journal-title":"Front Immunol"},{"key":"3892_CR14","doi-asserted-by":"publisher","first-page":"686501","DOI":"10.3389\/fimmu.2021.686501","volume":"12","author":"L Zhang","year":"2021","unstructured":"Zhang L, Qing P, Yang H, Wu Y, Liu Y, Luo Y. Gut microbiome and metabolites in systemic lupus erythematosus: link mechanisms and intervention. Front Immunol. 2021;12:686501.","journal-title":"Front Immunol"},{"key":"3892_CR15","doi-asserted-by":"publisher","first-page":"e01548","DOI":"10.1128\/mBio.01548-14","volume":"5","author":"A Hevia","year":"2014","unstructured":"Hevia A, Milani C, L\u00f3pez P, Cuervo A, Arboleya S, Duranti S, Turroni F, Gonz\u00e1lez S, Su\u00e1rez A, Gueimonde M, et al. Intestinal dysbiosis associated with systemic lupus erythematosus. mBio. 2014;5:e01548-01514.","journal-title":"mBio"},{"key":"3892_CR16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13099-016-0146-9","volume":"8","author":"Z He","year":"2016","unstructured":"He Z, Shao T, Li H, Xie Z, Wen C. Alterations of the gut microbiome in Chinese patients with systemic lupus erythematosus. Gut Pathog. 2016;8:64.","journal-title":"Gut Pathog"},{"key":"3892_CR17","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/art.41511","volume":"73","author":"BD Chen","year":"2021","unstructured":"Chen BD, Jia XM, Xu JY, Zhao LD, Ji JY, Wu BX, Ma Y, Li H, Zuo XX, Pan WY, et al. An autoimmunogenic and proinflammatory profile defined by the gut microbiota of patients with untreated systemic lupus erythematosus. Arthritis Rheumatol. 2021;73:232\u201343.","journal-title":"Arthritis Rheumatol"},{"key":"3892_CR18","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1042\/CS20180841","volume":"133","author":"Y Li","year":"2019","unstructured":"Li Y, Wang HF, Li X, Li HX, Zhang Q, Zhou HW, He Y, Li P, Fu C, Zhang XH, et al. Disordered intestinal microbes are associated with the activity of systemic lupus erythematosus. Clin Sci. 2019;133:821\u201338.","journal-title":"Clin Sci"},{"key":"3892_CR19","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1136\/annrheumdis-2018-214856","volume":"78","author":"D Azzouz","year":"2019","unstructured":"Azzouz D, Omarbekova A, Heguy A, Schwudke D, Gisch N, Rovin BH, Caricchio R, Buyon JP, Alekseyenko AV, Silverman GJ. Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal. Ann Rheum Dis. 2019;78:947\u201356.","journal-title":"Ann Rheum Dis"},{"key":"3892_CR20","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1128\/JB.183.12.3770-3783.2001","volume":"183","author":"BJ Paster","year":"2001","unstructured":"Paster BJ, Boches SK, Galvin JL, Ericson RE, Lau CN, Levanos VA, Sahasrabudhe A, Dewhirst FE. Bacterial diversity in human subgingival plaque. J Bacteriol. 2001;183:3770\u201383.","journal-title":"J Bacteriol"},{"key":"3892_CR21","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nm.3914","volume":"21","author":"X Zhang","year":"2015","unstructured":"Zhang X, Zhang D, Jia H, Feng Q, Wang D, Liang D, Wu X, Li J, Tang L, Li Y, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med. 2015;21:895\u2013905.","journal-title":"Nat Med"},{"key":"3892_CR22","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.chom.2017.06.014","volume":"22","author":"E Xiao","year":"2017","unstructured":"Xiao E, Mattos M, Vieira GHA, Chen S, Corr\u00eaa JD, Wu Y, Albiero ML, Bittinger K, Graves DT. Diabetes enhances IL-17 expression and alters the oral microbiome to increase its pathogenicity. Cell Host Microbe. 2017;22:120-128.e124.","journal-title":"Cell Host Microbe"},{"key":"3892_CR23","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1136\/gutjnl-2017-314814","volume":"67","author":"B Flemer","year":"2018","unstructured":"Flemer B, Warren RD, Barrett MP, Cisek K, Das A, Jeffery IB, Hurley E, O\u2019Riordain M, Shanahan F, O\u2019Toole PW. The oral microbiota in colorectal cancer is distinctive and predictive. Gut. 2018;67:1454\u201363.","journal-title":"Gut"},{"key":"3892_CR24","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1136\/gutjnl-2020-323826","volume":"70","author":"Z Ren","year":"2021","unstructured":"Ren Z, Wang H, Cui G, Lu H, Wang L, Luo H, Chen X, Ren H, Sun R, Liu W, et al. Alterations in the human oral and gut microbiomes and lipidomics in COVID-19. Gut. 2021;70:1253\u201365.","journal-title":"Gut"},{"key":"3892_CR25","doi-asserted-by":"publisher","first-page":"104708","DOI":"10.1016\/j.archoralbio.2020.104708","volume":"113","author":"BZ Li","year":"2020","unstructured":"Li BZ, Zhou HY, Guo B, Chen WJ, Tao JH, Cao NW, Chu XJ, Meng X. Dysbiosis of oral microbiota is associated with systemic lupus erythematosus. Arch Oral Biol. 2020;113:104708.","journal-title":"Arch Oral Biol"},{"key":"3892_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jaut.2018.10.009","volume":"97","author":"TA van der Meulen","year":"2019","unstructured":"van der Meulen TA, Harmsen HJM, Vila AV, Kurilshikov A, Liefers SC, Zhernakova A, Fu J, Wijmenga C, Weersma RK, de Leeuw K, et al. Shared gut, but distinct oral microbiota composition in primary Sj\u00f6gren\u2019s syndrome and systemic lupus erythematosus. J Autoimmun. 2019;97:77\u201387.","journal-title":"J Autoimmun"},{"key":"3892_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40168-017-0252-z","volume":"5","author":"JD Corr\u00eaa","year":"2017","unstructured":"Corr\u00eaa JD, Calderaro DC, Ferreira GA, Mendon\u00e7a SM, Fernandes GR, Xiao E, Teixeira AL, Leys EJ, Graves DT, Silva TA. Subgingival microbiota dysbiosis in systemic lupus erythematosus: association with periodontal status. Microbiome. 2017;5:34.","journal-title":"Microbiome"},{"key":"3892_CR28","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.","journal-title":"Arthritis Rheum"},{"key":"3892_CR29","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1136\/gutjnl-2017-315084","volume":"68","author":"Z Ren","year":"2019","unstructured":"Ren Z, Li A, Jiang J, Zhou L, Yu Z, Lu H, Xie H, Chen X, Shao L, Zhang R, et al. Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma. Gut. 2019;68:1014\u201323.","journal-title":"Gut"},{"key":"3892_CR30","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992;35:630\u201340.","journal-title":"Arthritis Rheum"},{"key":"3892_CR31","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","volume":"78","author":"A Fanouriakis","year":"2019","unstructured":"Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, Cervera R, Doria A, Gordon C, Govoni M, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78:736\u201345.","journal-title":"Ann Rheum Dis"},{"key":"3892_CR32","doi-asserted-by":"publisher","first-page":"2001936","DOI":"10.1002\/advs.202001936","volume":"7","author":"Z Ren","year":"2020","unstructured":"Ren Z, Fan Y, Li A, Shen Q, Wu J, Ren L, Lu H, Ding S, Ren H, Liu C, et al. Alterations of the human gut microbiome in chronic kidney disease. Adv Sci. 2020;7:2001936.","journal-title":"Adv Sci"},{"key":"3892_CR33","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/gutjnl-2018-317836","volume":"69","author":"Y Wei","year":"2020","unstructured":"Wei Y, Li Y, Yan L, Sun C, Miao Q, Wang Q, Xiao X, Lian M, Li B, Chen Y, et al. Alterations of gut microbiome in autoimmune hepatitis. Gut. 2020;69:569\u201377.","journal-title":"Gut"},{"key":"3892_CR34","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/s41396-017-0037-1","volume":"12","author":"C Chen","year":"2018","unstructured":"Chen C, Hemme C, Beleno J, Shi ZJ, Ning D, Qin Y, Tu Q, Jorgensen M, He Z, Wu L, Zhou J. Oral microbiota of periodontal health and disease and their changes after nonsurgical periodontal therapy. Isme j. 2018;12:1210\u201324.","journal-title":"Isme j"},{"key":"3892_CR35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/1529-0131(200201)46:1<175::AID-ART10015>3.0.CO;2-H","volume":"46","author":"P Gergely Jr","year":"2002","unstructured":"Gergely P Jr, Grossman C, Niland B, Puskas F, Neupane H, Allam F, Banki K, Phillips PE, Perl A. Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis Rheum. 2002;46:175\u201390.","journal-title":"Arthritis Rheum"},{"key":"3892_CR36","doi-asserted-by":"publisher","first-page":"4946711","DOI":"10.1155\/2021\/4946711","volume":"2021","author":"L Chodari","year":"2021","unstructured":"Chodari L, Dilsiz Aytemir M, Vahedi P, Alipour M, Vahed SZ, Khatibi SMH, Ahmadian E, Ardalan M, Eftekhari A. Targeting mitochondrial biogenesis with polyphenol compounds. Oxid Med Cell Longev. 2021;2021:4946711.","journal-title":"Oxid Med Cell Longev"},{"key":"3892_CR37","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s11306-015-0772-0","volume":"11","author":"A Perl","year":"2015","unstructured":"Perl A, Hanczko R, Lai ZW, Oaks Z, Kelly R, Borsuk R, Asara JM, Phillips PE. Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin. Metabolomics. 2015;11:1157\u201374.","journal-title":"Metabolomics"},{"key":"3892_CR38","doi-asserted-by":"publisher","first-page":"689044","DOI":"10.3389\/fimmu.2021.689044","volume":"12","author":"P Shen","year":"2021","unstructured":"Shen P, Lin W, Deng X, Ba X, Han L, Chen Z, Qin K, Huang Y, Tu S. Potential implications of quercetin in autoimmune diseases. Front Immunol. 2021;12:689044.","journal-title":"Front Immunol"},{"key":"3892_CR39","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.1007\/s11356-019-07232-1","volume":"27","author":"A Eftekhari","year":"2020","unstructured":"Eftekhari A, Hasanzadeh A, Khalilov R, Hosainzadegan H, Ahmadian E, Eghbal MA. Hepatoprotective role of berberine against paraquat-induced liver toxicity in rat. Environ Sci Pollut Res Int. 2020;27:4969\u201375.","journal-title":"Environ Sci Pollut Res Int"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-03892-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-03892-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-03892-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T06:11:46Z","timestamp":1675836706000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-03892-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,8]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3892"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-03892-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,8]]},"assertion":[{"value":"2 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was granted by the Ethics Committee of the First Affiliated Hospital of Zhengzhou University (2019-KY-200). Written informed consent of each participant was collected.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"95"}}